Detalles de la búsqueda
1.
Quality of life with second or third line nab-paclitaxel-based regimens in advanced non-small-cell lung cancer.
Future Oncol
; 16(12): 749-762, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32228198
2.
ABOUND.2L+: A randomized phase 2 study of nanoparticle albumin-bound paclitaxel with or without CC-486 as second-line treatment for advanced nonsquamous non-small cell lung cancer (NSCLC).
Cancer
; 124(24): 4667-4675, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30383906
3.
Nanoparticle Albumin-bound Paclitaxel Plus Carboplatin Induction Followed by Nanoparticle Albumin-bound Paclitaxel Maintenance in Squamous Non-Small-cell Lung Cancer (ABOUND.sqm): A Phase III Randomized Clinical Trial.
Clin Lung Cancer
; 22(1): 6-15.e4, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33097414
4.
nab-Paclitaxel/Carboplatin in Vulnerable Populations With Advanced Non-Small Cell Lung Cancer: Pooled Analysis.
Front Oncol
; 10: 485587, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33575203
5.
nab-Paclitaxel Plus Durvalumab in Patients With Previously Treated Advanced Stage Non-small Cell Lung Cancer (ABOUND.2L+).
Front Oncol
; 10: 569715, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33643895
Resultados
1 -
5
de 5
1
Próxima >
>>